Medical use of cannabis: Italian and European legislation

Canna Clinical TrialsLeave a comment

This review illustrates some brief considerations of the medical use of cannabis recently issued in Italy. History and uses of cannabisthroughout centuries and different countries are illustrated together with a description of botany and active phytocannabinoids. Then, medical use of cannabis anti-pain treatment for patients resistant to conventional therapies is described in case of chronic neuropathic pain, spasticity, for anticinetosic and antiemetic effect in nausea and vomiting caused by chemotherapy, for appetite stimulating effect in cachexia, anorexia, loss of appetite in cancer patients or patients with AIDS and in anorexia nervosa, hypotensive effect in glaucoma resistant to conventional therapies and for reduction of involuntary body and facial movements in Gilles de la Tourette syndrome.

Green Mountain at 25% of its Cannabis Crowdfunding Target

Cannabis news, Medical NewsLeave a comment

Green Mountain’s experienced team and strong partnerships are focused on cost effective and efficient production of medical cannabis PENTICTON, APRIL 25, 2018  FOR IMMEDIATE RELEASE Green Mountain Health Alliance reaches 25% of its equity crowdfunding target.PENTICTON, April 25, 2018 –  Green Mountain Health Alliance Ltd. (“Green Mountain” or the “Company”) the large-scale, low-cost, quality cannabis…

Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees

Canna Clinical TrialsLeave a comment

Overprescribing of opioids is considered a major driving force behind the opioid epidemic in the United States. Marijuana is one of the potential nonopioid alternatives that can relieve pain at a relatively lower risk of addiction and virtually no risk of overdose.  Marijuana liberalization, including medical and adult-use marijuana laws, has made marijuana available to more Americans. The potential of marijuana liberalization to reduce the use and consequences of prescription opioids among Medicaid enrollees deserves consideration during the policy discussions about marijuana reform and the opioid epidemic.

Medical Oncologists’ Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study

Canna Clinical TrialsLeave a comment

Background Although almost every state medical marijuana (MM) law identifies cancer as a qualifying condition, little research supports MM’s use in oncology. Oncologists’ beliefs, knowledge, and practices regarding MM were examined in this study. Although 70% of oncologists do not feel equipped to make clinical recommendations regarding MM, the vast majority conduct discussions with patients about MM and nearly one-half do, in fact, recommend it clinically. A majority believes MM is useful for certain indications.

Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism

Canna Clinical TrialsLeave a comment

The endocannabinoid (eCB) system plays a key role in many physiological and pathological conditions and its dysregulation has been described in several rheumatological and autoimmune diseases. Yet, its possible alteration in systemic lupus erythematosus (SLE) has never been investigated. Our data provides proof-of-concept to the development of cannabis-based medicine as immune-modulating agents.